Viewing Study NCT05796206


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-31 @ 5:42 PM
Study NCT ID: NCT05796206
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2023-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus
Sponsor: Beijing Mabworks Biotech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module